Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Harmatz

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Molecular Genetics and Metabolism|February 16, 2016
Implementing evidence-driven individualized treatment plans within Morquio A SyndromeLorne A Clarke, Paul Harmatz, Edward W Fong
Annals of the New York Academy of Sciences|December 13, 2005
Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometryRoland Fischer, Antonio Piga, Paul Harmatz, et al.
Pediatrics and Neonatology|December 4, 2022
Current and new therapies for mucopolysaccharidosesMonica Penon-Portmann, David R Blair, Paul Harmatz
International Ophthalmology|April 18, 2008
Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme) therapySelim T Koseoglu, Paul Harmatz, Sean Turbeville, et al.
Orphanet Journal of Rare Diseases|April 21, 2020
Assessing the impact of the five senses on quality of life in mucopolysaccharidosesRoberto Giugliani, Paul Harmatz, Shuan-Pei Lin, et al.
Molecular Genetics and Metabolism Reports|December 6, 2023
Clinical characteristics and somatic burden of patients with mucopolysaccharidosis II with or without neurological involvement: An analysis from the Hunter Outcome SurveyHeather Lau, Paul Harmatz, Jaco Botha, et al.
Orphanet Journal of Rare Diseases|December 3, 2021
Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): defining and measuring functional impacts in pediatric patientsBeth Leiro, Dawn Phillips, Melanie Duiker, et al.
Molecular Genetics and Metabolism|May 2, 2025
Safety of anesthesia in mucopolysaccharidoses - A comparative retrospective cohort study on more than 600 casesSimon Moser, Paul Harmatz, William Rhoads, et al.
Journal of Pediatric Rehabilitation Medicine|July 10, 2010
Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VIEllen B Fung, Jo Ann Johnson, Jacqueline Madden, et al.
Molecular Genetics and Metabolism Reports|May 31, 2018
Risks of long-term port use in enzyme replacement therapy for lysosomal storage disordersChristian J Hendriksz, Paul Harmatz, Roberto Giugliani, et al.
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Molecular Genetics and Metabolism|February 16, 2016
Implementing evidence-driven individualized treatment plans within Morquio A SyndromeLorne A Clarke, Paul Harmatz, Edward W Fong
Annals of the New York Academy of Sciences|December 13, 2005
Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometryRoland Fischer, Antonio Piga, Paul Harmatz, et al.
Pediatrics and Neonatology|December 4, 2022
Current and new therapies for mucopolysaccharidosesMonica Penon-Portmann, David R Blair, Paul Harmatz
International Ophthalmology|April 18, 2008
Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme) therapySelim T Koseoglu, Paul Harmatz, Sean Turbeville, et al.
Orphanet Journal of Rare Diseases|April 21, 2020
Assessing the impact of the five senses on quality of life in mucopolysaccharidosesRoberto Giugliani, Paul Harmatz, Shuan-Pei Lin, et al.
Molecular Genetics and Metabolism Reports|December 6, 2023
Clinical characteristics and somatic burden of patients with mucopolysaccharidosis II with or without neurological involvement: An analysis from the Hunter Outcome SurveyHeather Lau, Paul Harmatz, Jaco Botha, et al.
Orphanet Journal of Rare Diseases|December 3, 2021
Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): defining and measuring functional impacts in pediatric patientsBeth Leiro, Dawn Phillips, Melanie Duiker, et al.
Molecular Genetics and Metabolism|May 2, 2025
Safety of anesthesia in mucopolysaccharidoses - A comparative retrospective cohort study on more than 600 casesSimon Moser, Paul Harmatz, William Rhoads, et al.
Journal of Pediatric Rehabilitation Medicine|July 10, 2010
Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VIEllen B Fung, Jo Ann Johnson, Jacqueline Madden, et al.
Molecular Genetics and Metabolism Reports|May 31, 2018
Risks of long-term port use in enzyme replacement therapy for lysosomal storage disordersChristian J Hendriksz, Paul Harmatz, Roberto Giugliani, et al.
Pageof 16